Cargando…

Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes

AIMS/HYPOTHESIS: Diabetes is characterised by progressive loss of functional pancreatic beta cells. None of the therapeutic agents used to treat diabetes arrest this process; preventing beta cell loss remains a major unmet need. We have previously shown that serum from eight young healthy male parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Coomans de Brachène, Alexandra, Scoubeau, Corentin, Musuaya, Anyïshai E., Costa-Junior, Jose Maria, Castela, Angela, Carpentier, Julie, Faoro, Vitalie, Klass, Malgorzata, Cnop, Miriam, Eizirik, Decio L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676790/
https://www.ncbi.nlm.nih.gov/pubmed/36401627
http://dx.doi.org/10.1007/s00125-022-05837-9
_version_ 1784833674289610752
author Coomans de Brachène, Alexandra
Scoubeau, Corentin
Musuaya, Anyïshai E.
Costa-Junior, Jose Maria
Castela, Angela
Carpentier, Julie
Faoro, Vitalie
Klass, Malgorzata
Cnop, Miriam
Eizirik, Decio L.
author_facet Coomans de Brachène, Alexandra
Scoubeau, Corentin
Musuaya, Anyïshai E.
Costa-Junior, Jose Maria
Castela, Angela
Carpentier, Julie
Faoro, Vitalie
Klass, Malgorzata
Cnop, Miriam
Eizirik, Decio L.
author_sort Coomans de Brachène, Alexandra
collection PubMed
description AIMS/HYPOTHESIS: Diabetes is characterised by progressive loss of functional pancreatic beta cells. None of the therapeutic agents used to treat diabetes arrest this process; preventing beta cell loss remains a major unmet need. We have previously shown that serum from eight young healthy male participants who exercised for 8 weeks protected human islets and insulin-producing EndoC-βH1 cells from apoptosis induced by proinflammatory cytokines or the endoplasmic reticulum (ER) stressor thapsigargin. Whether this protective effect is influenced by sex, age, training modality, ancestry or diabetes is unknown. METHODS: We enrolled 82 individuals, male or female, non-diabetic or diabetic, from different origins, in different supervised training protocols for 8–12 weeks (including training at home during the COVID-19 pandemic). EndoC-βH1 cells were treated with ‘exercised’ serum or with the exerkine clusterin to ascertain cytoprotection from ER stress. RESULTS: The exercise interventions were effective and improved [Formula: see text] values in both younger and older, non-obese and obese, non-diabetic and diabetic participants. Serum obtained after training conferred significant beta cell protection (28% to 35% protection after 4 and 8 weeks of training, respectively) from severe ER stress-induced apoptosis. Cytoprotection was not affected by the type of exercise training or participant age, sex, BMI or ancestry, and persisted for up to 2 months after the end of the training programme. Serum from exercised participants with type 1 or type 2 diabetes was similarly protective. Clusterin reproduced the beneficial effects of exercised sera. CONCLUSIONS/INTERPRETATION: These data uncover the unexpected potential to preserve beta cell health by exercise training, opening a new avenue to prevent or slow diabetes progression through humoral muscle–beta cell crosstalk. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-022-05837-9) contains peer-reviewed but unedited supplementary material..
format Online
Article
Text
id pubmed-9676790
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-96767902022-11-21 Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes Coomans de Brachène, Alexandra Scoubeau, Corentin Musuaya, Anyïshai E. Costa-Junior, Jose Maria Castela, Angela Carpentier, Julie Faoro, Vitalie Klass, Malgorzata Cnop, Miriam Eizirik, Decio L. Diabetologia Article AIMS/HYPOTHESIS: Diabetes is characterised by progressive loss of functional pancreatic beta cells. None of the therapeutic agents used to treat diabetes arrest this process; preventing beta cell loss remains a major unmet need. We have previously shown that serum from eight young healthy male participants who exercised for 8 weeks protected human islets and insulin-producing EndoC-βH1 cells from apoptosis induced by proinflammatory cytokines or the endoplasmic reticulum (ER) stressor thapsigargin. Whether this protective effect is influenced by sex, age, training modality, ancestry or diabetes is unknown. METHODS: We enrolled 82 individuals, male or female, non-diabetic or diabetic, from different origins, in different supervised training protocols for 8–12 weeks (including training at home during the COVID-19 pandemic). EndoC-βH1 cells were treated with ‘exercised’ serum or with the exerkine clusterin to ascertain cytoprotection from ER stress. RESULTS: The exercise interventions were effective and improved [Formula: see text] values in both younger and older, non-obese and obese, non-diabetic and diabetic participants. Serum obtained after training conferred significant beta cell protection (28% to 35% protection after 4 and 8 weeks of training, respectively) from severe ER stress-induced apoptosis. Cytoprotection was not affected by the type of exercise training or participant age, sex, BMI or ancestry, and persisted for up to 2 months after the end of the training programme. Serum from exercised participants with type 1 or type 2 diabetes was similarly protective. Clusterin reproduced the beneficial effects of exercised sera. CONCLUSIONS/INTERPRETATION: These data uncover the unexpected potential to preserve beta cell health by exercise training, opening a new avenue to prevent or slow diabetes progression through humoral muscle–beta cell crosstalk. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-022-05837-9) contains peer-reviewed but unedited supplementary material.. Springer Berlin Heidelberg 2022-11-19 2023 /pmc/articles/PMC9676790/ /pubmed/36401627 http://dx.doi.org/10.1007/s00125-022-05837-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Coomans de Brachène, Alexandra
Scoubeau, Corentin
Musuaya, Anyïshai E.
Costa-Junior, Jose Maria
Castela, Angela
Carpentier, Julie
Faoro, Vitalie
Klass, Malgorzata
Cnop, Miriam
Eizirik, Decio L.
Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
title Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
title_full Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
title_fullStr Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
title_full_unstemmed Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
title_short Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
title_sort exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676790/
https://www.ncbi.nlm.nih.gov/pubmed/36401627
http://dx.doi.org/10.1007/s00125-022-05837-9
work_keys_str_mv AT coomansdebrachenealexandra exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes
AT scoubeaucorentin exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes
AT musuayaanyishaie exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes
AT costajuniorjosemaria exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes
AT castelaangela exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes
AT carpentierjulie exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes
AT faorovitalie exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes
AT klassmalgorzata exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes
AT cnopmiriam exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes
AT eizirikdeciol exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes